Terms and Conditions for the Issuance and Exercise of Stock Acquisition Rights
First written in FY2018-Q2. 11 of 16 entries say "Advanced", first in FY2019-Q1. Latest entry: 2026-07-21.
102 other companies' latest entry also says "Advanced".
- FY2026-H1AchievedAnnual report
「Number of stock acquisition rights (rights)* 407 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* 40,700 common shares (Note 2) Exercise period of the stock acquisition rights * From 18 July 2025 To 17 July 2055」
For the stock acquisition rights resolved with a maximum of 407 rights in the previous fiscal year, the issuance of 407 rights covering 40,700 common shares was completed on 17 July 2025. - FY2025AdvancedAnnual report
「Board resolution dated 19 June 2025 Number of stock acquisition rights: up to 417 (undetermined) Class, details and number of shares underlying the stock acquisition rights (shares): up to 41,700 common shares (undetermined)」
For the 15th series of stock acquisition rights, the issuance policy was disclosed with a maximum of 417 rights and 41,700 common shares for 4 directors and 12 executive officers. - FY2025-H1AdvancedAnnual report
「* The details as of the issuance of the stock acquisition right certificates (18 July 2024) are presented.」
For the issuance dated 18 July 2024, 351 stock acquisition rights covering 35,100 common shares were actually issued to 5 directors and 11 executive officers. The exercise period was from 19 July 2024 to 18 July 2054. - FY2024-Q1AchievedAnnual report
「At a meeting of the Company’s board of directors held on 20 June 2023, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights as stock options to the Company’s directors and executive officers, and issued them on 14 July 2023.」
The issuance of the 13th series of stock acquisition rights, previously disclosed with a maximum of 402 rights and 40,200 common shares, was completed for 6 directors and 10 executive officers. - FY2023AdvancedAnnual report
「Board resolution dated 20 June 2023 Number of stock acquisition rights: up to 402 (undetermined) Class, details and number of shares underlying the stock acquisition rights (shares): up to 40,200 common shares (undetermined)」
The issuance policy disclosed pursuant to the board resolution dated the filing date set a maximum of 402 rights and 40,200 common shares for the 13th series of stock acquisition rights, to be granted to 6 directors and 10 executive officers. - FY2023-Q1AdvancedAnnual report
「At a meeting of the Company’s board of directors held on 17 June 2022, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights as stock options to the Company’s directors and executive officers, and issued them on 14 July 2022.」
A total of 561 stock acquisition rights covering 56,100 common shares were actually issued as stock options to 6 directors and 12 executive officers. The exercise period was from 15 July 2022 to 14 July 2052. - FY2022-Q1AdvancedAnnual report
「At a meeting of the Company’s board of directors held on 18 June 2021, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights as stock options to the Company’s directors, audit & supervisory board members and executive officers, and issued them on 15 July 2021.」
A total of 596 stock acquisition rights covering 59,600 shares were actually issued to 9 directors, 3 audit & supervisory board members and 12 executive officers. - FY2021AdvancedAnnual report
「Board resolution dated 18 June 2021 Number of stock acquisition rights: up to 629 (undetermined) Class, details and number of shares underlying the stock acquisition rights: up to 62,900 common shares (undetermined)」
During the period through the filing date, the issuance policy for the 11th series of stock acquisition rights was disclosed, with 629 rights and 62,900 shares set as the maximums for 9 directors, 3 audit & supervisory board members and 13 executive officers. - FY2020AdvancedAnnual report
「8 directors of the Company 421 rights 3 audit & supervisory board members of the Company 19 rights 13 executive officers of the Company 308 rights 74,800 common shares of the Company」
For the issuance dated 15 July 2020, 748 stock acquisition rights covering 74,800 shares were issued to directors, audit & supervisory board members and executive officers. The exercise period was from 16 July 2020 to 15 July 2050. - FY2020-Q1AdvancedAnnual report
「8 directors of the Company 411 rights Number of stock acquisition rights to be allotted 3 audit & supervisory board members of the Company 19 rights 12 executive officers of the Company 281 rights ③ Class and number of shares underlying the stock acquisition rights 71,100 common shares of the Company」
On 12 July 2019, 711 stock acquisition rights covering 71,100 shares were issued to directors, audit & supervisory board members and executive officers. - FY2019RestatedAnnual report
「2018 eighth series of stock options 57,700 common shares From 18 July 2018 to 17 July 2048」
For the eighth series of stock acquisition rights, 57,700 shares remained outstanding and unexercised after vesting at the end of the fiscal year. - FY2019-Q1AdvancedAnnual report
「8 directors of the Company 360 rights Number of stock acquisition rights to be allotted 3 audit & supervisory board members of the Company 12 rights 12 executive officers of the Company 205 rights」
As a significant subsequent event, the disclosure states that 577 stock acquisition rights covering 57,700 shares were issued to directors, audit & supervisory board members and executive officers on 17 July 2018. The exercise period was from 18 July 2018 to 17 July 2048. - FY2018RestatedAnnual report
「2017 Stock Options After vesting (shares) Outstanding and unexercised 60,500」
For the seventh series of stock acquisition rights, 60,500 shares remained outstanding and unexercised after vesting at the end of the fiscal year. - FY2018-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Number of stock acquisition rights (rights) 605 Number of shares underlying the stock acquisition rights (shares) 60,500 Amount payable upon exercise of the stock acquisition rights (yen) ¥1 per share Exercise period of the stock acquisition rights From 26 August 2017 To 25 August 2047」
During the second quarter accounting period, 605 stock acquisition rights were issued, covering 60,500 shares, with an exercise price of ¥1 per share and an exercise period from 26 August 2017 to 25 August 2047.